Exagen Inc. Common Stock (NASDAQ: XGN) last traded at $8.42, up 3.06% on the session. The quote above updates while this page is open; the figures below are drawn from Exagen Inc. Common Stock’s own filings and are restated only when a new one is published.
Exagen Inc. Common Stock trades on NASDAQ under the ticker XGN. Its market capitalisation is $203.98 million.
Valuation measures for Exagen Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $203.98M |
|---|---|
| Enterprise value | $219.11M |
| Price / sales | 2.87 |
| Price / book | 16.70 |
| Beta | 2.36 |
Trailing-twelve-month figures tagged in Exagen Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $71.12M |
|---|---|
| Net income (TTM) | -$18.92M |
| EPS (TTM) | -$0.820 |
| Gross margin | 58.64% |
| Operating margin | -18.58% |
| Return on equity | -154.90% |
| Cash | $24.59M |
Range and volume for XGN over the past 52 weeks.
| 52-week high | $12.23 |
|---|---|
| 52-week low | $2.59 |
| Volume | 251.2K |
| Average volume | 330.0K |
| Previous close | $8.17 |
Invest a chosen dollar amount in Exagen Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell XGN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.